Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-17 @ 5:19 PM
Study NCT ID:
NCT02167958
Status:
COMPLETED
Last Update Posted:
2019-10-15
First Post:
2014-06-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Sponsor:
Rafic Farah, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
13-131
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None